Nathaniel S. Gardiner Enanta Pharmaceuticals Inc (ENTA) insider trading activity

Nathaniel S. Gardiner is Chief Legal Officer of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 75,688 shares of ENTA, which is worth approximately $828,783. The most recent transaction as insider was on Feb 26, 2024, when has been sold 5,187 shares (Common Stock) at a price of $8.99 per share, resulting in proceeds of $46,631. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.7K

0% 3M change

5.37% 12M change

Total Value Held $828,783

Nathaniel S. Gardiner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 26 2024	BUY Exercise of conversion of derivative security	$46,631 $8.99 p/Share	5,187 Added 6.41%	75,688 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$12,074 $12.41 p/Share	973 Reduced 1.36%	70,501 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	3,320 Added 4.44%	71,474 Common Stock
Dec 05 2023	SELL Open market or private sale	$23,227 $9.63 p/Share	2,412 Reduced 3.42%	68,154 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$15,136 $9.49 p/Share	1,595 Reduced 2.21%	70,566 Common Stock
Apr 18 2023	BUY Exercise of conversion of derivative security	$200,010 $30.0 p/Share	6,667 Added 7.69%	79,980 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$355,405 $52.77 p/Share	6,735 Reduced 8.41%	73,313 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	20,997 Added 20.78%	80,048 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$46,768 $44.33 p/Share	1,055 Reduced 1.76%	59,051 Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	21,000 Added 25.89%	60,106 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$59,803 $62.49 p/Share	957 Reduced 2.03%	46,239 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	3,034 Added 6.04%	47,196 Common Stock
Dec 01 2021	SELL Payment of exercise price or tax liability	$48,838 $87.68 p/Share	557 Reduced 0.93%	59,226 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	-	6,800 Added 10.21%	59,783 Common Stock
Dec 15 2020	SELL Payment of exercise price or tax liability	$65,481 $42.52 p/Share	1,540 Reduced 3.52%	42,248 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	-	5,250 Added 10.71%	43,788 Common Stock
Dec 03 2020	BUY Exercise of conversion of derivative security	$50,010 $30.0 p/Share	1,667 Added 4.15%	38,538 Common Stock
Nov 20 2020	BUY Grant, award, or other acquisition	-	7,600 Added 17.09%	36,871 Common Stock

NSG

Nathaniel S. Gardiner

Chief Legal Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Value

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to ENANTA PHARMACEUTICALS INC

Track Activities on ENTA

Account